US:
UK:
JAPAN:
- Report code : CMI-2172
- Industry : Medical Devices
- Published On : Jul 2019
- Pages : 211 Pages
- Format :
Press Release: Ureteral Stents Market to Surpass US$ 564.4 Million by 2026
Press Release: Ureteral Stents Market to Surpass US$ 564.4 Million by 2026
Ureteral Stents Market Insights
The main purpose of ureteral stents is to hold the ureter and maintain drainage of urine. These ureteral stents are used for several medical conditions such as blockage of the ureter, lithotripsy, and ureter healing. Urinary incontinence is one of the major medical conditions in which ureteral stents play a major role of controlling and regulating the urine flow. The duration of ureteral stent treatment is dependent on the person’s medical condition, it may be placed for a short duration or for long term treatment. However, ureteral stents may cause some side effects such as difficulty in physical activity.
Increasing prevalence of urolithiasis worldwide, owing to changes in lifestyle such as dietary habits or sedentary lifestyle is a major factor driving the ureteral stents market growth. Urolithiasis is a urologic disorder, and places a significant burden on the healthcare system. According to a study published in the National Center for Biotechnology Information (NCBI), in October 2018, an estimated 1 to 19% of the population in India is suffering from urolithiasis.
The global ureteral stents market was valued at US$ 359.9 million in 2018, and is expected to witness a CAGR of 5.8% during the forecast period (2018 – 2026).
Figure 1. Global Ureteral Stents Market Share, By Product Type
Source: Coherent Market Insights Analysis (2019)
Increasing number of product launches by key players is expected to drive growth of the global ureteral stents market. For instance, in April 2018, Dornier MedTech announced the launch and availability of AXIS Single-Use Digital Flexible Ureteroscope and Stone Management Products such as ureteral stents and guidewires at the 2019 American Urology Association Meeting in Chicago, U.S. In June 2019, Merit Medical Systems, Inc. acquired Brightwater Medical, Inc., to align Merit’s resolve drainage catheter portfolio with the Brightwater’s ConvertX biliary stent system to enhance the company’s sales outside the U.S.
Moreover, facility expansions by market players is expected to contribute to the market growth. For instance, in March 2019, Pnn Medical A/S announced its entry in the France market through its own operating sales force in February 2019.
Ureteral Stents Market- Regional Analysis
Regional segmentation of the global ureteral stents market includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness lucrative growth in the ureteral stents market, owing to presence of key players such as Becton, Dickinson and Company (Bard Medical), Cook Medical, and Teleflex Incorporated. Moreover, rising prevalence of kidney disorders in the region is also expected to contribute to the North America ureteral stents market growth. For instance, in November 2018, the National Health and Nutrition Examination Survey (NHANES) published their data regarding prevalence of kidney stone cases in the U.S. According to the 2013–2014 NHANES data, the prevalence of kidney stone in the U.S. was accounted for 10.1%.
Asia Pacific is also expected to show noteworthy market share in ureteral stents market owing to increasing approvals for ureteral stents from healthcare regulatory authorities in the region. For instance, in May 2018, Allium Medical received regulatory clearance from the China Food and Drug Administration (CFDA) to market its portfolio of urological systems that includes products such as minimally-invasive BPH implant and premium urological stents, in China.
The Europe market is also expected to witness significant growth owing to increasing presence of key players in the region. For instance, major players such as Teleflex Incorporated offer a wide range of ureteral stents such as superglide ureteral stents, antireflux valve DD stents, special ureteral stents which include integral stents with one pigtail, and integral stents closed with tips on both sides among others.
Figure 2: Global Ureteral Stents Market Value (US$ Mn), By Region
Source: Coherent Market Insights Analysis (2019)
Ureteral Stents Market - Competitive Landscape
Key players operating in the Ureteral Stents Market include HydrUStent, LDA, UROMED Kurt Drews KG, Taewoong Medical Co., Ltd., Pnn Medical A/S, Optimed Medizinische Instrumente GmbH, Applied Medical Resources Corporation, Allium Medical Solutions Ltd., Cook Group, Becton, Dickinson And Company, B. Braun Melsungen AG, Coloplast A/S, Q Urological Corporation, Boston Scientific Corporation, Olympus Corporation, and Teleflex Incorporated.
Ureteral stents are used to restore urine flow through blocked ureters and return the kidney to its normal function. Ureteral stents can be used for short term as well as long term. Kidney stone is a major disorder in which a ureteral stents are used. It is a small and flexible hollow tube that is placed into the ureter. There are different types of ureteral stents such as open end ureteral stents, closed end ureteral stents, JJ stents are widely used in the treatment of kidney diseases such as kidney stone, and for procedures such as kidney transplants.
Market Dynamics
The global ureteral stents market is ever changing and there is fierce competition in the market, in which market players are trying to innovate their stenting technologies for better performance and medical outcomes.
Companies are focused on developing technologies that can bypass limitations such as infection, discomfort, and other urological disorders. For instance, in January 2019, Q Urological Corporation developed an aqueous hydrogel biomaterial, pAguamedicina, and a patented processing method for production of very high aqueous content to produce 100% all hydrogel catheters and stents.
Increasing number of product approvals from regulatory agencies is also expected to generate significant demand for ureteral stents during the forecast period. For instance, in November 2018, BrightWater Medical, Inc. received the U.S. FDA approval for its ConvertX Nephroureteral Stent System for ureteral obstructions.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section
Table of Contents
*Browse 44 market data tables and 41 figures on “Ureteral Stents Market” - Global forecast to 2026”.
Asia Pacific Intelligence Center (India): 